| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/14/2006 | CN1785226A Phyllanth soft capsule and its prepn. method |
| 06/14/2006 | CN1785221A Powder injection contg. radix bupleuri and its prepn. method |
| 06/14/2006 | CN1785212A Novel cinobufogenin freeze-drying powder injection, its prepn. method and quality control method |
| 06/14/2006 | CN1785209A Special medicine prescription for treating skin moniliasis |
| 06/14/2006 | CN1785193A Amino acid (-) ofloxacin water soluble salt |
| 06/14/2006 | CN1785187A Method for refining raw material of venous administration fibranine, its quality control tech., its prepns. and its prepn. method |
| 06/14/2006 | CN1785184A Application of sophocarpine in use of making medicines |
| 06/14/2006 | CN1785174A Application of wogonin for preparing medicine to treat or prevent hepatitis B |
| 06/14/2006 | CN1785168A Application of rugose soft sulfo-acid in anti HIV-1 virus |
| 06/14/2006 | CN1785166A Method for quality control of infantile amfenac alkylamine |
| 06/14/2006 | CN1785162A Double-layered medicine tablets for eliminating Helicobacter pylori and its prepn. method |
| 06/14/2006 | CN1785028A Two use type Xianglan tea tobhacco |
| 06/14/2006 | CN1259422C Peptides derived from attachment (G) protein of respiratory syncytial virus |
| 06/14/2006 | CN1259331C Nucleoside analogue lipid derivative and salt thereof |
| 06/14/2006 | CN1259330C Heptaene macrolide polyketone antibiotic FR-008 compound |
| 06/14/2006 | CN1259328C Isopamicin and its salt and their prepn |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259105C Buccal tablet of recombined human interferon alpha 2b and producing method |
| 06/14/2006 | CN1259103C Prescription of medicine for preventing and treating fin rot of turbot |
| 06/14/2006 | CN1259101C Medicine for treating tinea peids |
| 06/14/2006 | CN1259090C Oral liquid for treating common cold and coughing |
| 06/14/2006 | CN1259079C Osteopathy treating ointment |
| 06/14/2006 | CN1259076C Chinese medicine for curing phthisis and preparing method thereof |
| 06/14/2006 | CN1259073C Liquid of lonicera and forsythia and coptis for treating infantile malnutrition and its preparing method |
| 06/14/2006 | CN1259058C Medicinal composition for treating liver disease, its preparation method and use |
| 06/14/2006 | CN1259056C Use of adenosine A3 receptor agonist for inhibition of viral replication |
| 06/14/2006 | CN1259055C Method for preparing azithromycin superfine powder by ultrasound emulsion dissolvent diffusion method |
| 06/14/2006 | CN1259054C Application of gentiopicrin in preparing medication for restraining hepatitis B virus |
| 06/14/2006 | CN1259053C Medicinal preparation containing erythromycine ethylsuccinate |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/14/2006 | CN1259043C Application of salvia acid in pharmacy |
| 06/14/2006 | CN1259039C Huoxiang Zhengqi liquid capsule and its preparation |
| 06/14/2006 | CN1259038C Radix bupleuri soft capsule pharmaceutics and preparation process thereof |
| 06/14/2006 | CN1259037C Orally disintegrating tablet of antiviral medicine and its preparation process |
| 06/13/2006 | USRE39128 Antibacteria drug; respiratory system disorders; otitis |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060809 Locked nucleic acid units may be used in a wide variety of applications, such as PCR primers, sequencing, synthesis of antisense oligonucleotides, diagnostics and the like |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060732 Antiacne; skin disorders; packaged separately |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060454 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 06/13/2006 | US7060302 Metal-containing compositions, preparations and uses |
| 06/13/2006 | US7060285 Dispersions for the formulation of slightly or poorly soluble agents |
| 06/13/2006 | US7060279 Compositions and methods for dendritic cell-based immunotherapy |
| 06/13/2006 | US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 06/13/2006 | US7060259 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/13/2006 | CA2387997C Process for preparing oxazolines from tetrahydrofurans |
| 06/13/2006 | CA2237194C Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
| 06/13/2006 | CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives |
| 06/08/2006 | WO2006060730A2 Potassium salt of an hiv integrase inhibitor |
| 06/08/2006 | WO2006060712A2 Potassium salt of an hiv integrase inhibitor |
| 06/08/2006 | WO2006060711A2 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition |
| 06/08/2006 | WO2006060617A1 Ascomycin crystalline forms and preparation thereof |
| 06/08/2006 | WO2006060177A1 Method for treating hiv infection through co-administration of tipranavir and gw873140 |
| 06/08/2006 | WO2006060175A1 Method for treating hiv infection through co-administration of tipranavir and sch-417690 |
| 06/08/2006 | WO2006060159A1 Method for treating hiv infection through co-administration of tipranavir and gw695634 |
| 06/08/2006 | WO2006059670A1 Chitosan complex |
| 06/08/2006 | WO2006059638A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | WO2006059400A1 Antibiotics fki-2140, method of producing the same and strain producing the same |
| 06/08/2006 | WO2006059344A1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection |
| 06/08/2006 | WO2006059176A1 Naturally occuring igm antibodies that bind lymphocytes |
| 06/08/2006 | WO2006059171A1 Medicinal compositions based on vegetable extracts |
| 06/08/2006 | WO2006059169A2 Antiviral and immunostimulating marine fish oil composition |
| 06/08/2006 | WO2006058457A1 α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOL-1-ETHANOL DERIVATIVES |
| 06/08/2006 | WO2006058436A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/08/2006 | WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 06/08/2006 | WO2006018431A3 Peptides for the treatment of herpes virus infections |
| 06/08/2006 | WO2005115097A3 Cyclic peptide antibiotics |
| 06/08/2006 | WO2005099671A3 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 06/08/2006 | WO2005093036A3 Inhibitors of siderophore biosynthesis in fungi |
| 06/08/2006 | WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/08/2006 | WO2005000878A8 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 06/08/2006 | WO2003077857A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122276 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 06/08/2006 | US20060122260 Intermediates for aromatic polyketides as selective anticancer and antiviral agents |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122211 HIV integrase inhibitors, pharmaceutical compositions and methods for their use |
| 06/08/2006 | US20060122203 2-Hydroxymethylcyclopropylidenemethylpurines and - pyrimidines as antiviral agents |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 06/08/2006 | US20060122154 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060122103 Dalfopristine/quinupristine combinations with cefpirome |
| 06/08/2006 | US20060121538 Peptides having affinity for the gp120 viral protein and use thereof |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121521 Cold-adapted equine influenza viruses |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |